Project Grant F32AI183654
Award Date
11/24/24
Completion Date
7/31/27
Dollars Obligated
$148K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $812,603 to the University of Houston System to develop selective calcium-dependent protein kinase 1 (CDPK1) inhibitors for the treatment of cryptosporidiosis. The goal is to refine a new class of CDPK1 inhibitors and define the optimal tissue targeting for efficient treatment of this parasitic disease, which poses a...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is providing $242,250 to develop vaccines against the cryptosporidium parasite. The goal is to create a vaccine that targets multiple life stages of the parasite to provide effective protection against cryptosporidiosis, a leading cause of diarrheal disease in sub-Saharan Africa and Asia. The research, conducted by a...
This $147,656 federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand the role of transmembrane proteins in the cell division process of the malaria parasite Plasmodium falciparum. The award, effective January 22, 2025 through October 31, 2027, will enable the integration of biochemical and super-resolution microscopy approaches to decipher...
This $1,108,345 federal Project Grant award, funded by the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074), supports research to characterize the evolutionary transition of host-microbe interactions from commensal symbionts to blood parasites in apicomplexan organisms, which include the parasites that cause malaria. The project, led by the University of Rhode Island, will use advanced microscopy and genomics to compare the cellular invasion machinery between...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will provide $616,588 to The Regents of the University of California, San Francisco (UCSF) over a 5-year period from June 2025 to May 2030. The grant will support research to identify and study new components of key pathways related to environmental sensing mechanisms in the fungal pathogen Cryptococcus neoformans,...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to investigate heme homeostasis mechanisms in the malaria parasite Plasmodium falciparum. The $153,056 award will fund a 1.5-year research project at The Washington University to identify and characterize heme-binding proteins that enable the parasite to maintain appropriate heme levels during blood stage replication....
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $387,783 in funding to The Pennsylvania State University (Penn State) from June 1, 2025 to May 31, 2030 to uncover host-induced changes in pathogenic human viral dynamics by targeting the first critical steps of virus entry into human host cells. The research program will integrate cryo-electron microscopy, structural mass spectrometry,...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $749,594 to study the role of the host sphingosine kinase 1 (SK1) pathway in controlling infection by the fungus Cryptococcus neoformans (CN) during immunodeficiency. The research aims to: 1) determine the immune mechanism by which SK1-S1P regulates the organization of CN granuloma, and 2) define the immune response by...
This federal Project Grant award of $375,000.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research into the functions of messenger ribonucleoproteins (mRNPs) in regulating mRNA metabolism and translation in the malaria parasite Plasmodium falciparum. The research aims to identify molecular markers for distinct mRNP granules, determine their compositions, and characterize their...
This $232,073 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 (Allergy and Infectious Diseases Research) aims to explore the phenomenon of replicative aging in the opportunistic fungal pathogen Cryptococcus neoformans (CN) and its implications during co-infection with HIV in AIDS patients. The research will investigate the host-pathogen dynamics between CN, HIV, and microglia, the predominant brain-resident macrophages, to understand...